The trial starts on Monday 11 July and will continue for three months to allow the College to determine levels of demand for such a service and, therefore, whether it should be made permanent.
Eleanor Ferguson, RCVS Acting Registrar, said: "This was a potential service identified in our Strategic Plan as a way of allowing veterinary professionals to have informal, confidential, discussions with members of the Professional Conduct Department about potential fitness to practise issues, short of formally raising a concern.
"Although any discussions via the new reporting line or email address will be confidential, if a veterinary surgeon or a veterinary nurse subsequently wishes to raise a formal concern about another veterinary professional, then they generally will need to identify both themselves and the individual in order to take it through our investigation process.
"We have developed a bespoke concerns form for members of the professions who do want to raise concerns about other professionals."
Veterinary surgeons and veterinary nurses who wish to contact a member of the RCVS Professional Conduct Department in confidence can do so by calling 07599 958 294 between 9am and 5pm, or by emailing reporting@rcvs.org.uk.
The bespoke concerns from for members of the profession can be downloaded from www.rcvs.org.uk/concerns.
Environmental household flea spray, Acclaim®, is now licensed to kill house dust mites. A common cause of allergies, house dust mites are present all year around, aggravating conditions such as atopic dermatitis.
Containing S-methoprene and permethrin, Acclaim is a fast-acting, odourless household spray which kills fleas and flea larvae and has 12 months' activity against flea egg development. It also kills ants, cockroaches, ticks and spiders and does not break down in sunlight in the home.
For information on CEVA Animal Health's complete range of household flea treatments, which includes the traditional pesticide sprays Acclaim® and Staykil® and the innovative non-pesticide product Skoosh®, please contact your local CEVA account manager.
RCVS Council has unanimously elected Mrs Jacqui Molyneux to become its new Junior Vice-President. She will take up office on RCVS Day, 1 July 2011.
Jacqui said: "As I have become more and more involved with the RCVS and the work of its committees I am amazed at the amount of work being done behind the scenes by both Council Members and the RCVS staff. It's sad that many of the profession live in fear of the RCVS as they are only aware of its regulatory function.
"During my time on the Officer team, communication with the profession will be a priority, not for the vocal minority, but with the silent majority who have no idea of the breadth of the work that the RCVS undertakes each year."
Jacqui graduated in 1981 from the University of Bristol and started her career in small animal practice in Liverpool, before moving to the North East, and setting up her own practice. Following its rebuilding, the practice was accredited as a Veterinary Hospital in 2002 and, four years later, has become RCVS Practice Standards Scheme accredited.
Since her election to the RCVS Council in 2005, Jacqui has chaired the Small Animal Certificate Board and served for four years on the Disciplinary Committee. She has also been Vice-Chairman of the Veterinary Nurses Council since 2007.
From 2009, Jacqui has chaired the RCVS Awarding Body Board, including the review of Veterinary Nursing.
Jacqui is currently President of the Society of Practising Veterinary Surgeons (SPVS). She is studying for a Masters in Clinical Oncology with the University of Birmingham, and holds an RCVS Certificate in Small Animal Surgery awarded in 2000.
The Disciplinary Committee of the Royal College of Veterinary Surgeons has refused an application for restoration to the RCVS Register from a Kent-based former veterinary surgeon struck off in 1994 for disregarding basic hygiene at his professional premises and failing to properly maintain a Controlled Drugs Register or patient records.
In June 1994, the Committee found that Mr Warwick John Seymour-Hamilton, at that time the only veterinary surgeon practising at premises at 9 Orchard Grove, Orpington, Kent, was guilty of disgraceful professional conduct and should have his name removed from the Register. The state and condition of the premises were found to be such as to risk the health and welfare of animals taken to the premises, and bring the profession into disrepute. An application made by Mr Seymour-Hamilton for restoration made in 1995 was refused.
At a restoration hearing on 18 June 2010, Mr Seymour-Hamilton told the Committee that he sought restoration to the Register because he wished to further his research work into plants with potential medicinal properties. Restoration, he said, would improve his professional status by giving him more credibility, particularly in terms of recognition by the medical and veterinary professions.
Mr Seymour-Hamilton said that he had no intention of returning to clinical practice immediately, and neither the Committee nor the College had heard of any adverse conduct by the applicant since his removal.
However, Caroline Freedman, Chairman of the Disciplinary Committee, noted that if Mr Seymour-Hamilton were to be restored, the Committee would have no power to prevent him from returning to general practice.
Mr Seymour-Hamilton's response to questioning by the Committee raised a number of concerns with respect to the future welfare of animals should restoration be granted. He told the Committee that he had not undertaken any relevant Continuing Professional Development in the past 15 years, and said he lacked knowledge of current relevant legislation, for example, the Animals (Scientific Procedures) Act 1986 and basic 'Cascade' prescribing requirements. He also said that he had not read the RCVS Guide to Professional Conduct in the past 15 years and that it would not be satisfactory for him immediately to return to general practice.
Ms Freedman said: "If the Committee were to reinstate the Applicant to the Register, it would have to be satisfied that he is competent and safe to practise immediately. The Committee has an obligation to protect the public and animal welfare and cannot simply accept his assurances that he would take steps to rectify his self-confessed shortcomings at some point in the future."
Having taken all the evidence presented into account, the Committee was not satisfied that Mr Seymour-Hamilton was fit to be restored to the Register and dismissed his application.
Fort Dodge, which supplies Bluetongue vaccine in continental Europe, has licensed its cattle vaccine in the UK and is now launching the product onto the UK market.
The company has already won and met tenders from several European governments, including France, Spain, Italy, Portugal Germany, Switzerland, Belgium and the Czech Republic for its Zulvac 8® Bovis vaccine and says it is the only international company to have produced vaccines for the most commonly occurring serotypes of the disease including 8, 4 and 1.
Approved by the VMD with a Provisional Marketing Authorisation, Zulvac 8 is available in 50 dose and 10 dose packs. The key claims are active immunisation against Bluetongue serotype 8 of cattle from 2.5 months old and a significant reduction of viraemia.
The vaccine is administered in 2 x 2 ml doses at three week intervals given by intra muscular injection and the product is supported by a fixed 2ml multidose applicator with Sterimatic needle protector and cleaning system to ensure accurate dosing and hygienic conditions.
John Hanley, Managing Director of Fort Dodge UK, said: "We were first to market with our Zulvac 8 product in three European countries and have received an Award for Agricultural Merit from the Spanish Government for our work in Bluetongue control. Following the licensing of Zulvac 8 Bovis in the UK we now have the opportunity to launch the product onto the UK market.
"In terms of pricing, Zulvac 8 is competitive per dose against other products in the market and it is supported by the experience gained in Europe with millions of animals already vaccinated. We're delighted that the VMD have authorised the vaccine and believe its availability can play a key role in protecting the UK's cattle from this dreadful disease."
The product is authorised for use by cattle farmers in the protection zone only, and will require veterinary prescription. Farmers can administer the vaccine to their cattle and the 2ml intra-muscular injection will be an advantage in aiding administration especially when used with Zulvac Bovis applicator with sterimatic needle protector and cleaning system.
The first batches will be available from veterinary wholesalers from week commencing 22nd September 2008.
Woodley Equipment Company Ltd has announced the launch of InSight rapid diagnostic test kits. The test range includes FeLV, FIV, FeLV-FIV Combi, Giardia, Canine Heartworm, Canine Parvovirus and with more tests in development.
The test kits are available to veterinary practices across the UK and to Woodley's global veterinary diagnostic distributors. Each test is based on a sandwich lateral flow immunochromatographic assay and contains 10 cassettes per box. The company says that the diagnostic kits are simple and easy to use and will provide point of care testing direct to the veterinary practice. The kits are stored at room temperature (2⁰C - 30⁰C).
The range of InSight Rapid Diagnostic Tests includes:
To place an order, email sales@woodleyequipment.com, fax 01204 669034, or telephone 01204 669033.
For more information, visit: http://www.woodleyequipment.com/.
Set up in 2012, the programme was developed to raise the standards of care and welfare of cats in the veterinary clinic, and to provide veterinary surgeons with practical solutions to problems that they face when dealing with their feline patients. The programme is also designed to boost business by strengthening the bond between the clinic and its feline clients.
Four years later, with 732 practices accredited worldwide (369 in the UK) and a further 1,000 US practices accredited under the American Association of Feline Practitioners scheme licensed from ISFM, the programme has become a well-recognised global standard in feline veterinary care. Last October, it was the winner of the 2016 Veterinary Record Innovation Award.
ISFM says it has now signed six new commercial partners for the scheme: Boehringer Ingelheim, Ceva Animal Health, Elanco, Idexx Laboratories, Merial and Royal Canin, and will be working with these partners to expand the programme further.
Dr Andy Sparkes, Veterinary Director of International Cat Care, ISFM’s parent charity, said: We are delighted to see how many clinics around the world have focused on becoming cat friendly and we can only expect this to grow again in 2017 with our new partners on board. We are looking forward to a very cat friendly 2017!"
Clinics interested in joining the scheme should visit: www.catfriendlyclinic.org for further information, including an extensive library of photographs from already-accredited clinics to provide inspiration and ideas.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Hyperthyroidism is a common endocrine disorder that affects thyroid production in older cats. It’s a lifelong condition that requires careful understanding and management by both vets and owners.
"The video presentation aims to illustrate how, with flexibility and precision, you can take control of hyperthyroidism and restore the natural poise of your hyperthyroid patients."
To watch the film and enter the competition, visit: www.dechra.co.uk/3greatreasons.
Competition closes February 28th 2017.
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
The four-day course, which is organised by Embryonics, will take place in Cheshire and runs from Monday 24 February to Thursday 27 February.
The course will cover the five-step Dutch method of foot trimming, which Ceva says is the most successful tried and tested method of trimming for reducing the incidence of lameness in the herd.
Course tutors include John Dawson MRCVS BVMS CertCHP Dip Cattle footcare and a Ceva representative will also present information on how the management of pain and inflammation fits into a comprehensive lameness treatment programme. The practical course is a recognised route to becoming a NACFT (National Association of Cattle Foot Trimmers) licensed foot trimmer.
Peter Keyte, ruminant business unit manager at Ceva, comments: "We would like to encourage livestock vets, farmers and professional foot trimmers to work more closely together, as a team, to help prevent lameness in cattle. We are therefore delighted to be supporting the industry by sponsoring this course, which will help raise welfare standards across the industry."
For further information on the Professional Foot Trimming course, please visit www.embryonicsltd.co.uk.
Merial has released the results of a survey - carried out in conjunction with VetSurgeon.org - into the use of nutraceuticals for the management of canine joint problems.
The company says the total market for nutraceutical products remains strong, holding a value of £8.9 million* in the UK, and that this indicates that despite increasing economic pressures, nutraceuticals are still valued by veterinary surgeons and owners as an important part of the management approach to canine joint disease.
The survey generated 163 responses. Results showed that whilst 58% of canine patients with joint health problems received only NSAIDs for treatment, 28% of patients received both NSAIDs and a joint health nutraceutical and 14% received a nutraceutical alone, demonstrating the importance that veterinary practitioners place on the use of nutraceuticals. The survey also showed that on average, UK vets stock and recommend at least two nutraceutical products.
Supleneo flex Product Manager Claire Edmunds said: “This eshot survey yielded some interesting results and the email received the second highest recorded opening rate this year, indicating that it is a topic of great interest. The survey confirmed that vets are actively recommending nutraceuticals, alongside NSAIDs, for canine patients with joint health problems. These data also show that the market remains stable as the level of dispensing correlates well with our previous research. To encourage even more growth in this sector and support the launch of Supleneo flex we have produced a range of support materials, including the provision of samples, money off next purchase vouchers and a loyalty programme. In this way we can continue to support vets in their management of canine joint problems.”
For more information call Merial on 0870 6000 123 or contact your Territory Manager.
The Royal College of Veterinary Surgeons has refused to release the McKelvey Report in full, despite Freedom of Information requests made by VetSurgeon.org and others.
According to the College, it had always been the intention of RCVS Officers that the full report, which considered the building works in the Lower Ground Floor of the RCVS offices in Belgravia House, and the implementation of a new database, would be published.
However, on the advice of solicitors (Penningtons), only the recommendations of the Report were published initially, in November.
This publication followed discussion of the full report (one sentence was redacted on legal advice) by RCVS Council on 3 November.
Freedom of Information requests for the full report were then received by the College, so further, external senior legal advice was sought.
This advice, from Counsel, confirmed the original view from solicitors that it would be inappropriate to publish the report in full because it includes personal data, which ought not to be made public, under the Data Protection Act.
The College claims the meat of the report is in the recommendations, which account for approximately 50% of the report, and which are being taken forward by Officers and RCVS Council, with plans to put an Audit and Risk Committee in place taking priority.
The recommendations of the report, which were adopted by Council, were published online on 11 November and are available to download from the 'Related documents' box, above right.
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
www.mooresortho.com
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
Topics covered will include practical applications of enrichment for zoo species, options for reproductive control in pet ferrets, challenges of exotics out-of-hours care, veterinary care of invertebrates and decision-making in wildlife cases.
The Association says that this year, there will be a greater focus on masterclasses, practical sessions and roundtable discussions, and that there will be plenty of new research, case reports, case series and the most recent advancements in the field of zoo, wildlife and exotic animal medicine.
There will be dedicated streams covering zoo health, nursing, exotic pets and wildlife health, together with a stream for students and new graduates.
The social programme includes the student-mentor mixer, a wine and canapés evening, a gala dinner and silent disco.
Registration fees have been held at the same level as 2019: tickets for non-members range from £410 for one day, to £760 for all three; members get a discount.
www.bvzs.co.uk
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
To refer a case: https://chestergates.org.uk/referral-services.
The course, which is led by Mental Health First Aid England, comprises of two day-long sessions, the first of which will take place on Tuesday 9th January 2024 from 9am – 5pm and the second on Thursday 11th January.
The course costs £40 per person, and is open to all those working in the veterinary professions.
Advancement of the Professions and Mind Matters Director, Angharad Belcher, said: “This day long training session will help people to gain an understanding of what mental health is and how to challenge stigma, to gain the knowledge and confidence to advocate or mental health awareness, provide them with the ability to spot the signs of mental ill health and the skills to support positive wellbeing, as well as give people the confidence to support someone who is in distress or may be experiencing a mental health issue.
“While these sessions are open to all working in the veterinary professions, we are particularly encouraging vets working in rural areas or in ambulatory work to get involved.
"All veterinary work has its challenges, but we know from MMI funded research conducted by Scotland’s Rural College that rural and ambulatory veterinary work comes with its own set of challenges which is often compounded by working alone or having relatively limited contact with colleagues.
"Those working in rural areas often play integral roles within their local communities and it is therefore important to provide people with the skills to not only look after their own mental health, but with the opportunities to learn how to best support their friends and colleagues too.”
https://vetmindmatters.org/training
239 members took part in the survey, 46% from independent practices and the remainder in corporates.
60% were clinical directors, partners or owners and 30% were in an assistant or associate role.
Other than COVID, the main barriers to providing EMS were not having enough time or energy to support a student (approx 46%), too much work to do (approx 37%), not enough veterinary staff (approx 33%), and not having housing for a student (approx 19%).
The top four things which respondents felt would improve the quality of EMS were a clearer understanding of students' needs (92%), longer placements to allow more confidence to build (84%), free training on how to coach students (78%) and more resources to help students and mentors (73%).
It was also suggested that because universities are effectively asking vets to do their job for them, they should be offering free CPD to help all vets deliver EMS effectively.
To enhance the EMS experience, SPVS has produced a pre-placement preparation form which outlines the practice requirements, an EMS induction form to help students consider their priorities and expectations for the placement and the a Skills Matrix which provides a framework to structure learning objectives and record progress.
For the full survey report and to access the resources, visit the SPVS website https://spvs.org.uk/ems-free-resources-gateway/
The Royal College has announced that a Legislative Reform Order (LRO) to reconstitute its disciplinary committees separately from its Council has been signed by Defra Minister David Heath, and will come into force on 6 April 2013.
The LRO will amend Part I of Schedule 2 of the Veterinary Surgeons Act 1966 (VSA) and require that the RCVS Preliminary Investigation and Disciplinary Committees are made up of veterinary surgeons and lay members who are not RCVS Council members, and who are appointed independently.
This will ensure that the same group of people is not responsible for setting the rules, investigating complaints and adjudication, and will bring lay people formally into the Preliminary Investigation Committee.
The LRO will also allow the RCVS to increase the pool of people available to investigate complaints and sit on disciplinary hearings, reducing the workload on the individual Committee members whose primary appointment is to RCVS Council.
The RCVS has been working on the LRO with Department of Environment, Food and Rural Affairs (Defra) officials since late 2010, and the Order was based on consultations undertaken by the RCVS and Defra.
According to the College, the Order was commended at every stage of Parliamentary scrutiny as an effective means to address the single biggest deficit of the VSA and to improve how the RCVS regulates the profession. During debate in Grand Committee of the House of Lords on 10 January, the RCVS received considerable praise for its strenuous efforts to modernise under the constraints of the present legislation, and the LRO received unanimous support.
Following the Order coming into force, the first external members will join the Disciplinary and Preliminary Investigation Committees from July 2013. After a two-year transition period, members of the RCVS Council will become ineligible for membership of these committees. Information about how to apply to join these committees will be available shortly.
President Jacqui Molyneux said: "I am delighted the LRO has been made and I am immensely thankful for the hard work of the Defra team and my colleagues in the College. The LRO is the single biggest reform to the regulation of veterinary surgeons since the 1966 Act, and it will bring the RCVS in line with regulatory best practice and improve the perception of the independence of the RCVS disciplinary processes."
The speakers are:
Dr Lappin said: “There are a number of significant changes in the management of SARS-CoV-2 that impact companion animal medicine and our staff members since our first webinar. I believe the information to be presented will be extremely valuable in helping your veterinary team continue to successfully navigate this pandemic.”
David Sutton, Global Technical Director at webinar sponsors MSD Animal Health, said “COVID-19 has presented an extraordinary challenge to the global community. MSD Animal Health is proud to support WSAVA in providing quality education to veterinary professionals who continue to go above and beyond in the care of companion animals during the pandemic.”
To register for the webinar, visit: http://bit.ly/wsavawebinar-covd19-registration
The course helps veterinary practices manage their dispensaries with up-to-date information on medicines regulations. It covers the main aspects of dispensing including an overview and update on legislation, using the cascade and the storing and disposal of medicines. There will also be sessions covering controlled drugs, dispensing mishaps and what to expect from an inspection.
Tutors Pam Mosedale, Donal Murphy, Michael Stanford, Mike Jessop and John Millward will deliver lectures via webinars throughout the day, which ends with a live streamed interactive Q+A session.
The course is suitable for vets, vet nurses and other staff who deal with the dispensing of medicines and the pharmacy.
Attendees will have access to supporting resources for approximately two weeks after the course, including electronic course notes and lectures from the day and an active discussion forum.
The Association says course meets the RCVS practice standards veterinary hospital dispensing course requirements and is ideal for the new PSS Medicines Award CPD requirement.
It is also AMTRA accredited and carries 43 AMTRA CPD points.
Attendance for the day is compulsory and an attendance register will be taken for the Live Q&A session.
Course organiser Pam Mosedale said: “We are very excited to be able to deliver the BSAVA Dispensing Course online and still allow for interaction between speakers and delegates in the live session. With Practice Standards and VMD visits restarting, it is fantastic that we are still able to support practices in these difficult times by ensuring they are complying with the Veterinary Medicines Regulations.”
The course costs £150.00 (incl. VAT) for BSAVA members and £225.00 (incl. VAT) for non-members. To book visit https://www.bsava.com/Education/CPD/Event-Detail/dateId/2099
The new 10ml (10-dose) and 100ml (100-dose) packs of Ingelvac PRRS EU are available now, and will complement the existing 50ml (50-dose) packs.
Callum Blair MRCVS, Swine Brand Manager at Boehringer Ingelheim, said: "Nobody likes to end up with part used bottles of any vaccine that then have to be discarded. The addition of Ingelvac PRRS EU 10-dose and 100-dose packs will provide choice for different sized units and help reduce wasted doses."
For more information, visit www.prrs.com.
The 15 minute video (see below) is hosted by Chris Dixon, veterinary ophthalmologist and director at Veterinary Vision Ophthalmic Referrals, who discusses things to consider when examining a patient with an ocular disorder. He offers practical advice on how to perform an ocular examination, including tips on how to use an ophthalmoscope effectively, examining the ocular structures including the front eye, distant direct examination, indirect examination and close direct examination.
Chris said: "This series of videos aims to help vets learn how to perform the fundamental techniques of ophthalmic examination, hopefully enabling them to spot potentially degenerative conditions earlier. The second video in particular delves into practical tips that vets can use within practice. The videos have been created in partnership with Bayer as part of their ongoing commitment to training, and aim to help ensure that chronic conditions, such as keratoconjunctivitis sicca (KCS), or dry eye, are diagnosed and treated early."
The veterinary practice waiting room display materials are designed to help practices educate dog owners on the signs and management of Dry Eye in the hope that the condition may be diagnosed and treated earlier and to emphasise the importance of ongoing treatment and management.
Hannah Watts, Group Product Manager at Bayer said: "It is important that dog owners with a predisposed breed are aware that their pet may be at risk of developing Dry Eye and are aware of the symptoms. Annual testing in at risk breeds for Dry Eye is recommended to help reach an early diagnosis and optimise the chances of a successful treatment outcome."
The Dry Eye practice display materials are available to order via the Bayer Vet Centre www.vetcentre.bayer.co.uk. Alternatively, ask your Bayer rep for more details.
fVtqNMj35c8
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
The new packaging uses fewer plastic components and a new cardboard box.
Sabrina Jordan, Virbac’s Equine Product Manager said: "The new cardboard component is a substantial step forward making the new packaging more environmentally friendly."
She added: "This new Equimax packaging has a fresh new look and is now available at wholesalers."